Overview
This pen delivers the KLOW Blend — GHK-Cu, TB-500, BPC-157, and KPV — in a pre-filled, ready-to-use format: 80mg total, no reconstitution required. The four components cover collagen signaling, VEGF-dependent angiogenesis, VEGF-independent cell migration, and intracellular inflammatory modulation — giving the blend two separate entry points into NF-κB pathway activity from a single pen.
Mechanism of Action
GHK-Cu drives collagen synthesis and matrix remodeling gene programs; BPC-157 signals through VEGFR2 and FAK phosphorylation; TB-500 acts via integrin αvβ3, Akt-eNOS, and actin-mediated migration. KPV completes the profile: transported into cells through PepT1, it directly inhibits IκB kinase and blocks NF-κB nuclear translocation — suppressing pro-inflammatory cytokine expression intracellularly, mechanistically distinct from TB-500's extracellular inflammatory modulation.
Specifications
- Format: Pre-filled multi-dose research pen
- Total Content: 80mg
- Composition: GHK-Cu + TB-500 + BPC-157 + KPV
- CAS Numbers: GHK-Cu: 49557-75-7 · BPC-157: 137525-51-0 · TB-500: 77591-33-4 · KPV: 66172-75-6
- Reconstitution: None required
Research Applications
- Multi-mechanism tissue repair modeling
- Dual NF-κB pathway inhibition studies
- PepT1-mediated intracellular signaling
- Dual-mechanism angiogenesis research
- Mucosal and epithelial inflammation models





